Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study
- PMID: 8553671
- DOI: 10.1007/BF00299776
Conversion of unresectable to resectable hepatoblastoma and long-term follow-up study
Abstract
In children with hepatoblastoma, cure or a prolonged disease-free interval can only be accomplished with surgical resection of the primary tumor. Less than 50% of children with hepatoblastoma are felt to have resectable tumors at the time of diagnosis. Clinical studies have recently focused on the hypothesis that adjuvant chemotherapy can convert the unresectable tumor to a tumor that can be resected. Short-term outcomes for patients treated with adjuvant chemotherapy and subsequent resection are nearly equal to those patients treated with initial resection followed by chemotherapy. This study is a review of the current literature of the chemotherapeutic conversion of unresectable hepatoblastoma and an update on the long-term follow-up of some of these patients.
Similar articles
-
[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].Klin Padiatr. 2003 May-Jun;215(3):159-65. doi: 10.1055/s-2003-39375. Klin Padiatr. 2003. PMID: 12778356 Clinical Trial. German.
-
Survival after liver transplantation for hepatoblastoma: a 2-center experience.J Pediatr Surg. 2008 Nov;43(11):1973-81. doi: 10.1016/j.jpedsurg.2008.05.031. J Pediatr Surg. 2008. PMID: 18970927
-
Improved long-term survival with preoperative chemotherapy for hepatoblastoma.J Pediatr Surg. 1997 Jul;32(7):999-1002; discussion 1002-3. doi: 10.1016/s0022-3468(97)90386-9. J Pediatr Surg. 1997. PMID: 9247221 Clinical Trial.
-
Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.J Pediatr Surg. 2004 Feb;39(2):195-8; discussion 195-8. doi: 10.1016/j.jpedsurg.2003.10.012. J Pediatr Surg. 2004. PMID: 14966739 Review.
-
Hepatoblastoma: an oncological review.Pediatr Radiol. 2006 Mar;36(3):183-6. doi: 10.1007/s00247-005-0064-3. Epub 2006 Jan 11. Pediatr Radiol. 2006. PMID: 16404556 Review.
Cited by
-
The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.BMC Cancer. 2011 Aug 19;11:362. doi: 10.1186/1471-2407-11-362. BMC Cancer. 2011. PMID: 21854558 Free PMC article.
-
Hepatoblastoma: a single institutional experience of 18 cases.Pediatr Surg Int. 2008 Jul;24(7):799-802. doi: 10.1007/s00383-008-2169-x. Epub 2008 May 6. Pediatr Surg Int. 2008. PMID: 18458915
-
Single-walled carbon nanohorn aggregates promotes mitochondrial dysfunction-induced apoptosis in hepatoblastoma cells by targeting SIRT3.Int J Oncol. 2018 Sep;53(3):1129-1137. doi: 10.3892/ijo.2018.4459. Epub 2018 Jun 28. Int J Oncol. 2018. PMID: 29956732 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Medical